The company is also gearing up for expansion in the US and European markets with their CE and FDA certification under process
Agatsa, medtech company in the cardiac problem diagnostic segment, has raised Rs 125 million to grow business operations and expand the product line. The company has innovated pocket 12-Lead ECG device which is being used by both doctors and heart patients in India for quick diagnosis/detection of cardiac problems. With this new funding, the med-tech brand aims to make its products more accessible.
Key investors include seasoned medical experts Dr Ramakant Panda, MCh, Chief Consultant for Cardiovascular Thoracic Surgery and the Vice Chairman and MD of the Asian Heart Institute, BKC, Mumbai; Dr Tejas Patel, a renowned cardiologist and Chairman of Apex Heart Institute, Ahmedabad; Dr Ashish Parikh, Interventional Clinical Cardiologist and Chairman of Heart and Vascular Clinic in Delaware, USA, Ahmedabad based Desai Family and Hemal Patel, serial entrepreneur. Fairprep Ally (India) represented by CEO Nirav Thakkar, based in Ahmedabad, Gujarat has facilitated the funding transaction as the investment banker.
Agatsa has been expanding its B2B collaborations with hospitals, digital health firms, diagnostic labs and local clinics. SanketLife is the flagship product of Agatsa, which is an Internet of Things (IoT) platform consisting of a portable and touch-based ECG machine that has been designed to make heart health screening easier and more affordable for everyone via the smartphone app and a cloud platform. The company is also gearing up for expansion in the US and European markets with their CE and FDA certification under process.